JPMorgan director defers annual stock grant
JPMorgan Chase & Co. director Michele Buck reported an acquisition of common stock tied to her board compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
JPMorgan Chase & Co. director Michele Buck reported an acquisition of common stock tied to her board compensation. On January 20, 2026, she acquired 913.5251 shares of common stock at $306.505 per share through a deferral of her annual stock grant, which will be paid in shares upon termination of her service as a director. Following this transaction, she beneficially owns 918.5251 shares of JPMorgan common stock in direct ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 913.5251 | $306.505 | $280K |
Footnotes (1)
- F1. Deferral of annual stock grant, payable in shares of JPM stock upon termination of service as a director.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did JPM (JPMorgan Chase & Co.) report for Michele Buck?
Michele Buck, a director of JPMorgan Chase & Co., reported acquiring 913.5251 shares of common stock on January 20, 2026 under transaction code A.
What is the nature of Michele Bucks JPM stock grant reported on this Form 4?
The filing states the transaction is a deferral of an annual stock grant, payable in JPM shares upon termination of her service as a director.
What is Michele Bucks relationship to JPMorgan Chase & Co. in this filing?
In this filing, Michele Buck is identified as a director of JPMorgan Chase & Co. and not as an officer or 10% owner.
AI-generated analysis. How Rhea-AI works. Not financial advice.